A01K 2217/058
Due to expression of inhibitory nucleic acid
Official title: due to expression of inhibitory nucleic acid, e.g. siRNA, antisense
A01K2217/058 (Due to expression of inhibitory nucleic acid) appears on 69 US grants and 177 published applications in this corpus.
Search patents in A01K- Granted patents
- 69
- Published applications
- 177
- Assignees
- 102
- Inventors
- 309
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 2 |
| 2004 | 1 | 3 |
| 2005 | 0 | 11 |
| 2006 | 0 | 10 |
| 2007 | 0 | 12 |
| 2008 | 2 | 20 |
| 2009 | 3 | 14 |
| 2010 | 4 | 17 |
| 2011 | 4 | 11 |
| 2012 | 7 | 7 |
| 2013 | 6 | 10 |
| 2014 | 7 | 7 |
| 2015 | 5 | 6 |
| 2016 | 5 | 5 |
| 2017 | 2 | 5 |
| 2018 | 3 | 8 |
| 2019 | 4 | 6 |
| 2020 | 1 | 3 |
| 2021 | 3 | 3 |
| 2022 | 2 | 2 |
| 2023 | 5 | 4 |
| 2024 | 1 | 2 |
| 2025 | 3 | 6 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Endonuclease sexing and sterilization in insects12 May 2026US 12,622,419 B2The Regents of the University of California
- Animal model for hepatocellular carcinoma and uses thereof8 Jul 2025US 12,349,665 B2National Yang-Ming University
- Process of transfecting primordial germ cells in an avian25 Feb 2025US 12,232,488 B2Aviagen
- Process for using CRISPR to transfect primordial germ cells in avians4 Feb 2025US 12,213,466 B2Aviagen
- Non-human animals comprising a humanized TTR locus and methods of use18 Jun 2024US 12,010,979 B2Regeneron Pharmaceuticals, Inc.
- Compositions and methods for generating porcine ovarian tumor model6 Aug 2026US 2026/0223823 A1Georgia Tech Research Corporation
- Biomarker for predicting risk of drug addiction relapse and animal model with high relapse of drug addiction9 Jul 2026US 2026/0193304 A1Korea Institute of Science and Technology
- Method and animal model for inducing bcc tumors5 Feb 2026US 2026/0033466 A1Feldan Bio Inc.
- Dna editing using single-stranded dna16 Oct 2025US 2025/0320527 A1Board of Regents of the University of Nebraska
- Pirna-based constructs for regulating gene expression and methods of use thereof7 Aug 2025US 2025/0248379 A1Rutgers, The State University of New Jersey
Most cited
By later US patents
- Isolation of novel AAV'S and uses thereof107US 9,217,155 B2University of Massachusetts · 2015
- Therapeutic uses of inhibitors of RTP80198US 7,741,299 B2Quark Pharmaceuticals, Inc. · 2010
- Polyconjugates for in vivo delivery of polynucleotides74US 8,137,695 B2Arrowhead Madison Inc. · 2012
- Polyconjugates for in vivo delivery of polynucleotides69US 8,658,211 B2Arrowhead Madison Inc. · 2014
- Isolation of novel AAV's and uses thereof63US 9,596,835 B2University of Massachusetts · 2017